Champions Oncology (CSBR) vs MiNK Therapeutics (INKT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
MiNK Therapeutics (INKT) has outperformed Champions Oncology (CSBR) over the past year, losing 23.4% versus a loss of 25.4%. Over five years, CSBR leads with a -51.6% price change compared with -90.5% for INKT. Champions Oncology is the larger company by market cap ($67.9 million vs $56.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CSBR | INKT |
|---|---|---|
| Share price | $4.88 | $11.01 |
| Market cap | $67.85M | $56.18M |
| 1-day change | -0.10% | -3.59% |
| YTD return | -29.38% | +2.42% |
| 1-year return | -25.38% | -23.36% |
| 5-year return | -51.59% | -90.48% |
| Forward P/E | 48.75 | — |
| EPS (TTM) | $-0.07 | $-2.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.31 | $16.93 |
| 52-week low | $4.59 | $8.48 |
| Distance from 52-week high | -41.34% | -34.96% |
| Average volume | 11.50K | 14.20K |
| Shares outstanding | 13.92M | 5.10M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CSBR vs INKT FAQ
Which is bigger, Champions Oncology or MiNK Therapeutics?
Champions Oncology (CSBR) is larger, with a market capitalization of $67.85M compared with $56.18M for MiNK Therapeutics (INKT).
Which stock has performed better over the past year, CSBR or INKT?
INKT returned -23.36% over the past 12 months, compared with -25.38% for CSBR (price return, excluding dividends). Past performance does not predict future results.
Are Champions Oncology and MiNK Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.